AstraZeneca Amenities Building - Mississauga - Sept 2005
Non exclusive, unlimited time license for print & web to WZMH Architects

AZ sells potential Crohn's drug to Allergan

AstraZeneca is continuing its strategy of out-licensing drugs outside its core areas, selling off a mid-stage pipeline Crohn’s disease drug to Allergan in a deal potentially worth more than